*  Immunologic adjuvant
MF59 is an 'oil [squalene] in water' adjuvant used in some human vaccines. An increasing number of vaccines with squalene and ... malaria and tuberculosis). A study claims that Docosahexaenoic acid (DHA) may help prevent aluminum induced biochemical and ... "Guideline on Adjuvants in Vaccines for Human Use" (PDF). The European Medicines Agency. Retrieved 8 May 2013. DNA Vaccines: ... PMID 26344622 PMC 4494261/ Baylor N, Egan W, Richman P (2002). "Aluminum salts in vaccines--US perspective". Vaccine. 20 (Suppl ...
*  Vaccine-preventable diseases
... tuberculosis, and yellow fever. The WHO reports licensed vaccines being available to prevent, or contribute to the prevention ... Vaccine-preventable deaths are usually caused by a failure to obtain the vaccine in a timely manner. This may be due to ... If a vaccine-preventable disease is uncommon in a country, then residents of that country are unlikely to receive a vaccine ... A vaccine-preventable disease is an infectious disease for which an effective preventive vaccine exists. If a person acquires a ...
*  Mycobacterium vaccae
... killed Mycobacterium vaccae oral vaccine and An Hui Longcom's killed Mycobacterium vaccae oral vaccine in treating tuberculosis ... "Extremely drug resistant tuberculosis - is there hope for a cure?" (PDF). TB Alert - the UK's National Tuberculosis Charity. ... Mycobacterium vaccae is in the same genus as Mycobacterium tuberculosis, the bacterium which causes tuberculosis. Numerous ... The research team reported greater success with the Immunitor vaccine than the An Hui Longcom vaccine. A team of researchers at ...
*  Tuberculosis vaccines
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB ... MVA85A rBCG30 72F fusion protein ESAT6-Ag85b fusion protein New vaccines are being developed by the Tuberculosis Vaccine ... booster vaccines to supplement BCG Pre-infection Booster to BCG Post-infection Therapeutic vaccine Since the BCG vaccine does ... "Childhood Tuberculosis: Old And New Vaccines." Paediatric Respiratory Reviews 8.2 (2007): 148-154. Print. Verma, Indu, and Ajay ...
*  MVA85A
"Tuberculosis vaccine hopes dashed". BBC News. Retrieved 4 February 2013. "Effects of MVA85A vaccine on tuberculosis challenge ... is a new-generation vaccine against tuberculosis developed by researchers at Oxford University. This vaccine produces higher ... "Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design". ... 2008). "Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa". J Infect Dis. 198 ...
*  Francesco Dieli
Tuberculosis Vaccine Initiative (TBVI), member. UNICEF/UNDP/World Bank/ WHO Special Programme for Research and Training in ... immune response against Mycobacterium tuberculosis and cancer immunotherapy. Professor Dieli has been involved in over 150 ...
*  Stefan H.E. Kaufmann
His vaccine against tuberculosis is currently in phase II clinical trial assessment. Moreover, Kaufmann is actively involved in ... Gilla Kaplan, Ph.D. (2005-10-13). "Rational Vaccine Development - A New Trend in Tuberculosis Control". New England Journal of ... Insciences "Clinical trial for new tuberculosis vaccine". Max Planck Society. 2008-09-11. Retrieved 2010-06-19. ... the rational design and development of a better vaccine against tuberculosis as well as of biomarkers for reliable diagnosis of ...
*  American Cyanamid
One was tuberculosis vaccine, another was Sabin polio vaccine.[citation needed] Cyanamid was the sole producer of buttons for U ... an oral polio vaccine and sought contribution from American Cyanamid Company, the parent company of the vaccine manufacturer. ... vaccines, many others; and Davis & Geck, surgical sutures and devices); Formica Corp. (subsidiary, making decorative laminates ... Stresstabs vitamins and Orimune the Sabin oral polio vaccine - was Cyanamid's pharmaceutical division. Davis & Geck was the ...
*  Modified vaccinia Ankara
P. Andersen, J. S. Woodworth: Tuberculosis vaccines-rethinking the current paradigm. In: Trends in immunology. Band 35, Nummer ... The Modified Vaccinia Ankara (MVA) is an attenuated vaccine of a poxvirus. It was licensed and used as a poxvirus vaccine in ... In macaques, DNA-based HIV vaccines can be effectively boosted with recombinant MVA-based vaccines expressing HIV antigens. ... Immunization regimens incorporating priming with DNA vaccine and boosting with recombinant MVA-based vaccine have been found to ...
*  BCG vaccine
Bacillus Calmette-Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis. In countries where tuberculosis is ... See: Tuberculosis vaccines "BCG Vaccine: WHO position paper" (PDF). Weekly epidemiological record. 4 (79): 25-40. Jan 23, 2004 ... "Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?" (PDF). Vaccine. 23 (17-18): ... The BCG vaccine can be anywhere from 0 to 80% effective in preventing tuberculosis for a duration of 15 years; however, its ...
*  World Tuberculosis Day
"Tuberculosis Vaccine Initiative". "International Union Against Tuberculosis and Lung Disease - Tuberculosis". "World Health ... Epidemiology of tuberculosis The Global Fund to Fight AIDS, Tuberculosis and Malaria World Health Organization, Tuberculosis. ... Tuberculosis: a killer that can't be kept behind bars, ICRC News release, 22.03.2010 Tuberculosis: stopping a killer that can't ... World Tuberculosis Day, observed on March 24 each year, is designed to build public awareness about the global epidemic of ...
*  72F fusion protein vaccine
... is a candidate tuberculosis vaccine created by Statens Serum Institut (SSI). The 72F fusion protein ... vaccination strategies against AIDS and tuberculosis". Nature Medicine. 11 (4 suppl): S33-S44. PMID 15812488. doi:10.1038/ ... is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed ...
*  Texas Biomedical Research Institute
Rigby, Wendy (21 August 2017). "San Antonio Scientist Wins Big Grant To Develop Novel Tuberculosis Vaccine". Texas Public Radio ... Research on preventing and treating Mycobacterium tuberculosis with particular emphasis on TB and aging, diabetes, and vaccine ... Developed vaccines, antibodies and antitoxins for deadly agents of bioterrorism such as Ebola, botulinum neurotoxins, and ... Developing vaccine strategies for Ebola, HIV, Lassa virus, West Nile virus, Japanese encephalitis viruses, and herpes. ...
*  List of Bulgarian inventors and discoverers
Grigorov made a major contribution to the creation of an anti-tuberculosis vaccine. Dimitar Paskov - created the medicine ...
*  Nicholas Georgescu-Roegen
During the war, Georgescu lost his only brother due to a fatal reaction to a tuberculosis vaccine. Upon his return from the US ...
*  Sanofi Pasteur
The resulting closure of the plant for over two years resulting in shortages of bladder cancer and tuberculosis vaccines. The ... "Sanofi Pasteur Vaccine Hub". www.vaccinehub.com.au. Retrieved 1 March 2014. "sanofi-aventis : Sanofi Pasteur, the vaccine ... such as a tuberculosis vaccine ImmuCYST, a BCG Immunotherapeutic -a bladder cancer drug. By April 2012 the FDA had found dozens ... Influenza Virus Vaccine, No Preservative - influenza Fluzone, Influenza Virus Vaccine, No Preservative: Ped Dose - influenza ...
*  Stamen Grigorov
Grigorov made a major contribution to the creation of an anti-tuberculosis vaccine. On 20 December 1906, in Paris in issue No. ... 104 of the "La Presse Médicale" medical journal, was published his scientific report "The Anti-tuberculosis vaccine", which ... Grigorov's vaccine. Through his scientific experiments "in-vitro" and "in-vivo" on lab animals and later on human patients, Dr ... Grigorov clearly demonstrated and described the healing effect of penicillin fungi in the treatment of tuberculosis. Grigorov ...
*  Lloyd J. Old
Introduced Bacille Calmette-Guérin (BCG), the tuberculosis vaccine, into experimental cancer research as a way to stimulate non ... Establishment in 2001 of the Cancer Vaccine Collaborative (CVC), the world's first network of clinical trial sites closely ... vaccine delivery platforms, and modulators of immune suppression. Founder of "The Academy of Cancer Immunology [which] was ... where from 2001 to 2011 he also served as director of the CRI/LICR Cancer Vaccine Collaborative (CVC), an international network ...
*  Samuel H. Golter
... tuberculosis vaccines were beginning to significantly decrease the prevalence of tuberculosis, and the need for sanatoriums was ... Under his leadership, the institution transitioned from a small tuberculosis treatment center to a major research, teaching, ... a small tuberculosis sanatorium near Los Angeles which treated patients for free. The Jewish Consumptive Relief Association ( ... to build a new medical building and facilities for the treatment of diseases such as cancer in addition to tuberculosis. Golter ...
*  Saint Louis University School of Medicine
... and tuberculosis vaccines. Actually, the Saint Louis School of Medicine is one of only eight NIH-funded vaccine research ... neurosciences and vaccine research among others. It is a leading center of research in five key areas: cancer, infectious ... and vaccine development". Effective April 1, 2008, Philip O. Alderson, former chairman of the radiology department at Columbia ... vaccine development, cardiac health, and afflictions of the liver. Currently, numerous cutting edge research projects are ...
*  Rudolph John Anderson
... he focused his research on isolating the sterols of the tubercle bacillus which resulted in the making of Tuberculosis vaccine ... In 1948 he was awarded the Trudeau Medal from the National Tuberculosis Association, and in 1951 became an honorary member of ...
*  TBVI
This vaccine, used since 1921, can protect children from severe forms of tuberculosis. However, BCG has little to no efficacy ... The TuBerculosis Vaccine Initiative (TBVI) is a non-profit foundation that facilitates the discovery and development of new, ... On suggestion of the European Commission, in 2008, the TuBerculosis Vaccine Initiative (TBVI) was founded to collect additional ... research institutes and private industry in the TB vaccine field. Tuberculosis is a terrible disease and an urgent global ...
*  London School of Hygiene & Tropical Medicine
HIV/AIDS and other sexually transmitted diseases malaria and other vector borne diseases tuberculosis vaccine development and ... Child Health Vaccine Centre Wellcome Bloomsbury Centre All three Faculties offer a wide range of MSc courses and Research ...
*  Ireland's Greatest
... introduced the BCG tuberculosis vaccine to Ireland John Tyndall, (1820-1893) physicist who studied radiant energy in air Harry ...
*  Queen's University
... developed the first clinically effective immunotherapy for cancer by adapting the Bacille Calmette-Guérin tuberculosis vaccine ...
*  Diseases of poverty
While the tuberculosis rate is decreasing in the rest of the world, it is increasing by rate of 6 percent per year in Sub- ... Malaria vaccines are an area of intensive research. Intestinal parasites are extremely prevalent in tropical areas. These ... Tuberculosis is the leading cause of death around the world for an infectious disease. This disease is especially prevalent in ... Tuberculosis: Commentary on a Reemergent Killer. Barry R. Bloom and Christopher J. L. Murray. Centers for Disease Control and ...
*  European Centre for Disease Prevention and Control
... including HIV and Blood-borne Viruses Influenza Tuberculosis Vaccine-preventable Diseases Two shared-resource units - ...